Alvotech and Dr. Reddy's partner for AVT03, a biosimilar to Prolia and Xgeva, treating osteoporosis and skeletal-related events. The agreement includes exclusive US commercialization rights.
Popular Posts
-
The Department of Telecommunications (DoT) has not yet issued demand notes to telecom firms for payment of spectrum won in the latest aucti...
-
Two challengers hoping to deny New York City Mayor Eric Adams a second term say they’ve raised hundreds of thousands of dollars in donation...
